Merck nears clinical tests for coronavirus vaccine candidates
Bio Pharma Dive
JULY 31, 2020
Two candidates recently acquired in deals with IAVI and Themis have shown promise in preclinical studies, Merck executives said, and Phase 1 trials will begin later this year.
Let's personalize your content